← Back to Search

Laser Therapy

Fractional CO2 Laser for Hypertrophic Scars

N/A
Waitlist Available
Led By Frankie Fraulin, MD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 8 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a special laser treatment to improve raised scars in children aged 1-17. The laser makes tiny, controlled injuries in the scar tissue, which helps the skin heal better and reduces symptoms like pain and itching. The goal is to find the best way to use this laser treatment to make it safe and effective for kids. Laser treatments have been used for a long time to improve the appearance and symptoms of burn scars, showing effectiveness in children.

Eligible Conditions
  • Hypertrophic Scar

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 8 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 8 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Cutometer measurements
Change in POSAS score
Change in SCAR-Q score
Secondary study objectives
Change in appearance on Clinical Photographs of scars

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Laser treatment half of scarExperimental Treatment1 Intervention
The other half of the scar will receive standard scar treatment with topical products and pressure garments and, in addition, will receive ablative fractional CO2 laser treatment
Group II: Control half of scarActive Control1 Intervention
one half of the scar will receive standard scar treatment with topical products and pressure garments, but no ablative fractional CO2 laser

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
808 Previous Clinical Trials
884,383 Total Patients Enrolled
Frankie Fraulin, MDPrincipal InvestigatorClinical Associate Professor

Media Library

Fractional CO2 Laser Treatment (Laser Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT04236167 — N/A
Hypertrophic Scar Research Study Groups: Control half of scar, Laser treatment half of scar
Hypertrophic Scar Clinical Trial 2023: Fractional CO2 Laser Treatment Highlights & Side Effects. Trial Name: NCT04236167 — N/A
Fractional CO2 Laser Treatment (Laser Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04236167 — N/A
~1 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top